PTEN and acute lymphoblastic leukemia: We observed no difference between PTEN mutated and wild-type transplanted leukemias with respect to AS605240 effect, which raises the question if T-ALL patients may benefit from PI3K inhibition irrespectively of PTEN mutational status.